<DOC>
	<DOCNO>NCT01094795</DOCNO>
	<brief_summary>The primary purpose study assess incidence rate target infection , malignancy mortality among patient rheumatoid arthritis treat abatacept .</brief_summary>
	<brief_title>Safety Study Abatacept Sweden</brief_title>
	<detailed_description />
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>Resident Sweden</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>